EFTA00606967.pdf

Report Status: Partial 4 1) Quest —60 Diagnostics' EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR911482U Client #: 17436 56W5265 EPSTEIN, JEFFREY Requisition: 0021277 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 UCA/MOSKOWITZ BRUCE MD Gender: M Attn: **P GR/UNIV.CLINICAL Collected: 06/24/2016 Phone: 561.366.0084 1411 N FLAGLER DR STE 7100 Received: 06/27/2016 10:03 EDT Patient ID: 19530120MJE WEST PALM BEACH, FL 33401 Reported: 06/27/2016 16:51 EDT Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab LIPID PANEL CHOLESTEROL, TOTAL 184 125-200 mg/dL MI HDL CHOLESTEROL 29 L > OR = 40 mg/dL MI TRIGLYCERIDES 375 H <150 mg/dL MI LDL-CHOLESTEROL 80 <130 mg/dL (talc) MI Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 6.3 H < OR = 5.0 (talc) MI NON HDL CHOLESTEROL 155 mg/dL (talc) MI Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 1.1 mg/L MI Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 14.2 H <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 90 65-99 mg/dL Fasting reference interval UREA NITROGEN (BUN) 24 7-25 mg/dL CREATININE 0.99 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 81 > OR = 60 mL/min/1.73m2 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR911482U PAGE I OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00606967  Report Status: Partial raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR9 I 1482U Client #: 17436 EPSTEIN, JEFFREY Collected: 06/24/2016 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 Received: 06/27/2016 / 10:03 EDT Gender: M Reported: 06/27/2016 / 16:51 EDT Patient ID: 19530120MM Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab eGFR AFRICAN AMERICAN 94 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (talc) SODIUM 138 135-146 mmol/L POTASSIUM 4.3 3.5-5.3 mmol/L CHLORIDE 104 98-110 mmol/L CARBON DIOXIDE 16 L 19-30 mmol/L CALCIUM 9.6 8.6-10.3 mg/dL PROTEIN, TOTAL 6.8 6.1-8.1 g/dL ALBUMIN 4.3 3.6-5.1 g/dL GLOBULIN 2.5 1.9-3.7 g/dL (talc) ALBUMIN/GLOBULIN RATIO 1.7 1.0-2.5 (talc) BILIRUBIN, TOTAL 0.8 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 56 40-115 U/L AST 19 10-35 U/L ALT 18 9-46 U/L HEMOGLOBIN A1c 6.2 H <5.7 % of total Hgb MI According to ADA guidelines, hemoglobin Alc <7.0% represents optimal control in non-pregnant diabetic patients. Different metrics may apply to specific patient populations. Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013:36:s11-s66 For the purpose of screening for the presence of diabetes <5.7% Consistent with the absence of diabetes 5.7-6.4% Consistent with increased risk for diabetes (prediabetes) >or=6.5% Consistent with diabetes This assay result is consistent with a higher risk of diabetes. Currently, no consensus exists for use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 7.4 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL TSH 2.26 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.4 4.5-12.0 mcg/dL MI FREE T4 INDEX (T7) 2.4 1.4-3.8 T3 UPTAKE 32 22-35 % MI SED RATE BY MODIFIED MI WESTERGREN 9 < OR - 20 mm/h CSC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 7.5 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.24 4.20-5.80 Million/uL HEMOGLOBIN 14.8 13.2-17.1 g/dL HEMATOCRIT 44.5 38.5-50.0 % MCV 84.9 80.0-100.0 fL MCH 28.2 27.0-33.0 pg MCHC 33.2 32.0-36.0 g/dL RDW 14.4 11.0-15.0 % PLATELET COUNT 266 140-400 Thousand/uL MPV 8.0 7.5-11.5 fL ABSOLUTE NEUTROPHILS 4050 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2438 850-3900 cells/uL CLIENTSERIIICES:866.6971378 SPECIMEN: MR9 I 1482U PAGE 2OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00606968  Report Status: Partial Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR911482U Client #: 17436 EPSTEIN, JEFFREY Collected: 06/24/2016 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 Received: 06/27/2016 / 10:03 EDT Gender: M Reported: 06/27/2016 / 16:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab ABSOLUTE MONOCYTES 480 200-950 cells/uL ABSOLUTE EOSINOPHILS 495 15-500 cells/uL ABSOLUTE BASOPHILS 38 0-200 cells/uL NEUTROPHILS 54.0 LYMPHOCYTES 32.5 MONOCYTES 6.4 EOSINOPHILS 6.6 BASOPHILS 0.5 URINALYSIS, COMPLETE MI See Endnote 2 FOLATE, SERUM 12.7 ng/mL MI Reference Range Low: <3.4 Borderline: 3.4-5.4 Normal: >5.4 C-REACTIVE PROTEIN 0.10 <0.80 mg/dL MI Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.7 2.0-18.0 ng/mL MI TESTOSTERONE, TOTAL, MI MALES (ADULT), IA 149 L 250-827 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than approximately 300 ng/dL may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. Two morning (8-10 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.5 < OR = 4.0 ng/mL MI This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. Endnote 1 * Test not performed. * * No specimen received. * CLIENT SERVICES: 866.697.8378 SPECIMEN: MR911482U PAGE30F5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00606969  Report Status: Partial raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR911482U Client #: 17436 EPSTEIN, JEFFREY Collected: 06/24/2016 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 63 Received: 06/27/2016 / 10:03 EDT Gender: M Reported: 06/27/2016 / 16:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab VITAMIN D,25.OH,TOTAL,IA 36 30-100 ng/mL MI Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: http://education.questdiagnostics.com/faq/FAQ163 (This link is being provided for informational/educational purposes only.) Physician Comments: Infectious Diseases Test Name Result Reference Range Lab HIV 1/2 ANTIGEN/ANTIBODY, FOURTH GENERATION W/RFL MI HIV AG/AB,4TH GEN I NON-REACTIVE I NON-REACTIVE HIV-1 antigen and HIV-1/HIV-2 antibodies were not detected. There is no laboratory evidence of HIV infection. PLEASE NOTE: This information has been disclosed to you from records whose confidentiality may be protected by state law. If your state requires such protection, then the state law prohibits you from making any further disclosure of the information without the specific written consent of the person to whom it pertains, or as otherwise permitted by law. A general authorization for the release of medical or other information is NOT sufficient for this purpose. For additional information please refer to http://education.questdiagnostics.com/faq/FAQ106 (This link is being provided for informational/ educational purposes only.) The performance of this assay has not been clinically validated in patients less than 2 years old. CLIENTSERVICES:866.697.8378 SPECIMEN: MR911482U PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00606970  Report Status: Partial raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR911482U Client #: 17436 EPSTEIN, JEFFREY Collected: 06/24/2016 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 63 Received: 06/27/2016 / 10:03 EDT Gender: M Reported: 06/27/2016 / 16:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Infectious Diseases Test Name Result Reference Range Lab Physician Comments: Infectious Diseases Test Name Result Reference Range Lab HEPATITIS PANEL, ACUTE W/REFLEX TO CONFIRMATION HEPATITIS A IGM I NON-REACTIVE I NON-REACTIVE MI HEPATITIS B SURFACE ANTIGEN W/REFL CONFIRM MI HEPATITIS B SURFACE ANTIGEN NON-REACTIVE NON-REACTIVE HEPATITIS B CORE ANTIBODY (IGM) NON-REACTIVE NON-REACTIVE MI HEPATITIS CAB W/REFL TO HCV RNA, ON, PCR MI HEPATITIS C ANTIBODY NON-REACTIVE NON-REACTIVE SIGNAL TO CUT-OFF 0.02 <1.00 Physician Comments: PENDING TESTS: TESTOSTERONE, FREE LC/MS/MS PERFORMING SITE: MI QUEST DIAGNOSTICS.NIIAMI. I0RI0 COMMERCE PARKWAY. MIRAMAR. FL 3.360-5.3938 Laboraumy DINCIOI: GLEN L. NORM MD PHD. WA: I 0D0277334 CLIENT SERVICES: SPECIMEN: MR911482U PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00606971